Clin2
NCT07315841Possibly a fitRecruiting

Dye Imaging for Tenosynovial Giant Cell Tumor Surgery

Tenosynovial Giant Cell Tumor

Treatments studied

Part of Bones, joints & muscles, Cancer clinical trials.

This trial tests whether a special dye (Indocyanine Green) used during surgery can help doctors see Tenosynovial Giant Cell Tumors more clearly. It may help make the surgery more precise.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
40 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must have a confirmed diagnosis of Tenosynovial Giant Cell Tumor (a growth in the tissue around tendons) from a biopsy or MRI.
  • You must be scheduled for surgery to remove the tumor.
  • You cannot have a severe allergy to Indocyanine Green (a dye used during the procedure) or iodine.
  • You must not have severe liver problems.
  • You cannot be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07315828Recruiting· Phase 4
ICG imaging to improve surgery for giant cell bone tumors

This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.

Shanghai
NCT06647901Recruiting· Phase 1/Phase 2
ICG dye imaging for giant cell tumor surgery

This trial uses a special dye (ICG) and a camera to help surgeons see the tumor better during surgery for giant cell tumors of bone in the arms or legs. The goal is to remove all of the tumor while saving as much healthy bone as possible.

Beijing, Beijing Municipality
NCT06979115Not yet recruiting
ICG dye imaging to guide bone and soft tissue tumor surgery

This trial tests whether a special dye called ICG, which glows under infrared light, can help surgeons better see and remove bone and soft tissue tumors during surgery. The goal is to make the removal more precise and safe.

Guangzhou, Guangdong
NCT04084067Recruiting· Phase 1
ICG dye helps surgeons remove tumors

This early-phase study tests whether a special dye can help doctors see a tumor more clearly during surgery in children and young people. If you have a solid tumor or certain lymphomas that need removal, the dye may help guide the surgeon to the right tissue.

Memphis, Tennessee
NCT04723810Recruiting· Phase 1/Phase 2
Test a glowing scan to help surgeons find tumor tissue

This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.

Philadelphia, Pennsylvania
NCT06227338Recruiting
Testing a dye to see breast cancer during surgery

This trial uses a special dye called ICG that makes cancer glow under a special camera during breast cancer surgery. Doctors want to find the best time to give the dye so they can see the cancer clearly and remove all of it in one operation.

Brussels

Hear when a new Tenosynovial Giant Cell Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.